34.7 C
Tuesday, April 16, 2024

Russia approves clinical trials of modified Sputnik V vaccine


Russia’s Ministry of Health has authorised clinical trials of a modified version of Russia’s Sputnik V vaccine against COVID-19, the data from the registry of approved clinical trials has shown.

“The goal of the clinical study: to evaluate the safety, reactogenicity and immunogenicity of the Gam-COVID-Vac vector vaccine [Sputnik V] for the prevention of coronavirus infection caused by the SARS-CoV-2 virus with a modified antigenic profile in adult volunteers,” the line in the registry has shown.

The clinical study will be completed on December 31, 2024. As many as 100 volunteers are expected to participate in the trials, according to the registry.

An authorisation has also been issued to carry out clinical trials of a modified coronavirus vaccine for children aged 12-17, and the trials will be completed on December 31, 2024, the registry has shown.

Alexander Gintsburg, the director of Moscow-based Gamaleya National Center for Epidemiology and Microbiology, which developed the Sputnik V vaccine, told Sputnik in April that vaccines against COVID-19 should be modified every 9-10 months to be effective.

Share post:




More like this

Theft at Teliamura Class XII English Medium School

By TC News Desk Agartala, April 15: Teliamura Class XII...

Postal voting commences for service workers at Shishu Bihar HS School, RO Dr Vishal Kumar oversees process

BY TC News Desk Agartala, 15th April 2024:  The crucial...

Pujan rejoins Congress, Sudip accuses BJP of destroying campaigning materials

BY TC News Desk Agartala, 15th April 2024:  Pujan Biswas,...

Vote for BJP to strengthen PM Modi’s hand: CM urges voters

BY TC News Desk Agartala, 15th April 2024:  Chief Minister...